Clustering data with hclust algorithm for NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? (Study ST000257)

ESI positive ion mode (Ceramide analysis) (Analysis AN000408)
MetaboliteStructureF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15
18:1 SphingosineME7019390.27NA2.400.230.020.13NA3.450.220.030.67NA4.320.240.03
C24 dihydroceramideME7019380.08NA2.370.030.280.07NA3.370.03NA0.15NA3.110.03NA
C24 CeramideME7019340.122.541.810.040.040.073.242.000.040.010.282.372.360.070.02
C14 CeramideME7019360.133.750.330.040.020.175.210.520.050.010.203.980.530.040.01
C16 CeramideME7019350.243.440.530.030.030.155.070.740.030.020.273.640.780.040.01
C18:1 CeramideME7019330.014.330.000.010.000.006.180.000.010.000.004.440.000.010.00
C18 dihydroceramideME7019370.035.030.000.020.010.015.000.010.030.000.014.800.010.030.00
C18 CeramideME7019320.014.600.000.020.000.005.480.000.020.000.004.820.010.030.00
C20 CeramideME7019400.034.560.240.000.010.025.440.100.000.000.034.390.150.000.00

Factors:

F1Treatment:HFD | Tissue Type:Adipose
F2Treatment:HFD | Tissue Type:Hypothalmus
F3Treatment:HFD | Tissue Type:Liver
F4Treatment:HFD | Tissue Type:Muscle
F5Treatment:HFD | Tissue Type:Plasma
F6Treatment:LFD | Tissue Type:Adipose
F7Treatment:LFD | Tissue Type:Hypothalmus
F8Treatment:LFD | Tissue Type:Liver
F9Treatment:LFD | Tissue Type:Muscle
F10Treatment:LFD | Tissue Type:Plasma
F11Treatment:SW | Tissue Type:Adipose
F12Treatment:SW | Tissue Type:Hypothalmus
F13Treatment:SW | Tissue Type:Liver
F14Treatment:SW | Tissue Type:Muscle
F15Treatment:SW | Tissue Type:Plasma
Data matrix
  logo